India's Sun Pharma reports higher adjusted quarterly profit on strong domestic demand - Reuters
2 days ago • Google News
Sun Pharmaceutical Industries Limited (SUNPHARMA)
NSEINR 1629.7-4.51%
Price Chart
Key Statistics
Market Cap
INR 3.91T
P/E Ratio
37.59
Revenue (TTM)
INR 537.77B
Volume
8.77M
52W High
INR 1942.23
52W Low
INR 1547.96
Dividend Yield
0.00%
Beta
0.36
Technicals
50-Day MA
1680.73
200-Day MA
1737.0532
52 Week High
1942.2259
52 Week Low
1547.9647
About SUNPHARMA
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, th.
Employees
43000
Headquarters
Mumbai, India
CEO
Mr. Dilip Shantilal Shanghvi
Latest News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
39.89
Percentile: 86.78
Environmental Risk Score
3.07
Percentile: 4
Social Risk Score
25.2
Percentile: 4
Governance Risk Score
18.13
Percentile: 4
Controversy Level
ESG data provided by Sustainalytics, Inc.
SUNPHARMA
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg